The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study

被引:131
作者
Dowling, NF
Austin, H
Dilley, A
Whitsett, C
Evatt, BL
Hooper, WC
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div HIV STD & TB Lab Res, Haematol Dis Branch, Atlanta, GA 30333 USA
[2] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[3] Mt Sinai Sch Med, New York, NY USA
关键词
epidemiology; factor V Leiden; prothrombin; venous thromboembolism;
D O I
10.1046/j.1538-7836.2003.00031.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to assess, comprehensively, medical and genetic attributes of venous thromboembolism (VTE) in a multiracial American population. The Genetic Attributes and Thrombosis Epidemiology (GATE) study is an ongoing case-control study in Atlanta, Georgia, designed to examine racial differences in VTE etiology and pathogenesis. Between 1998 and 2001, 370 inpatients with confirmed VTE, and 250 control subjects were enrolled. Data collected included blood specimens for DNA and plasma analysis and a medical lifestyle history questionnaire. Comparing VTE cases, cancer, recent surgery, and immobilization were more common in caucasian cases, while hypertension, diabetes, and kidney disease were more prevalent in African-American cases. Family history of VTE was reported with equal frequency by cases of both races (28-29%). Race-adjusted odds ratios for the associations of factor V Leiden and prothrombin G20210A mutations were 3.1 (1.5, 6.7) and 1.9 (0.8, 4.4), respectively. Using a larger external comparison group, the odds ratio for the prothrombin mutation among Caucasians was a statistically significant 2.5 (1.4, 4.3). A case-only analysis revealed a near significant interaction between the two mutations among Caucasians. We found that clinical characteristics of VTE patients differed across race groups. Family history of VTE was common in white and black patients, yet known genetic risk factors for VTE are rare in African-American populations. Our findings underscore the need to determine gene polymorphisms associated with VTE in African-Americans.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 32 条
[1]  
Alhenc-Gelas M, 1999, THROMB HAEMOSTASIS, V81, P506
[2]   Factor V leiden and factor V R2 allele: High-throughput analysis and association with venous thromboembolism [J].
Benson, JM ;
Ellingsen, D ;
El-Jamil, M ;
Jenkins, M ;
Miller, CH ;
Dilley, A ;
Evatt, BL ;
Hooper, WC .
THROMBOSIS AND HAEMOSTASIS, 2001, 86 (05) :1188-1192
[3]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[4]   Effect of the MTHFRC677T variant on risk of venous thromboembolism:: Interaction with factor V Leiden and prothrombin (F2G20210A) mutations [J].
Brown, K ;
Luddington, R ;
Baglin, T .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) :42-44
[5]   A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (Factor V:Q(506)) [J].
Cattaneo, M ;
Tsai, MY ;
Bucciarelli, P ;
Taioli, E ;
Zighetti, ML ;
Bignell, M ;
Mannucci, PM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (09) :1662-1666
[6]   The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation [J].
De Stefano, V ;
Martinelli, I ;
Mannucci, PM ;
Paciaroni, K ;
Chiusolo, P ;
Casorelli, I ;
Rossi, E ;
Leone, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (11) :801-806
[7]   Prevalence of the prothrombin 20210 G-to-A variant in blacks: Infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects [J].
Dilley, A ;
Austin, H ;
Hooper, WC ;
El-Jamil, M ;
Whitsett, C ;
Wenger, NK ;
Benson, J ;
Evatt, B .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 132 (06) :452-455
[8]  
Emmerich J, 2001, THROMB HAEMOSTASIS, V86, P809
[9]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[10]  
GOLDHABER SZ, 1994, HAEMOSTASIS THROMBOS, V3, P1327